OR WAIT null SECS
Center, expected in 2023, will support pharma and med device sectors
UPS is launching a healthcare facility in Dublin, Ireland. Opening in late 2023, the new facility will offer nearly 65,000 square feet of space to connect Ireland’s growing pharma and medical technology industries to UPS’s smart global logistics network that serves customers in over 220 countries and territories.
The center will support Ireland’s pharma and medical device industries in providing biologics, vaccines, and healthcare equipment to patients around the world. It will initially create 30 jobs, as the logistics provider has expressed commitment to the Irish market and support for its long-term export growth.
The announcement comes at a time when 80% of pharmaceutical drugs in the EU require cold chain logistical support and temperature-controlled transportation. More than 50% of all new drugs in the global pharmaceutical pipeline are cutting edge biomedical drugs, such as vaccines, that tend to be temperature-sensitive, according to analysis conducted by Allied Market Research.
“This is a significant investment by UPS in Ireland and a demonstration of our commitment to enabling truly global healthcare supply chains,” comments Cathy O’Brien, UPS Healthcare’s VP for international sales. “Our new facility supports the quality and regulatory needs of manufacturers, many of whom are providing critical upstream activity, and we provide them with resiliency and scale.”